AbbVie Inc
(LTS:0QCV)
$
174.92
-0.4 (-0.23%)
Market Cap: 302.34 Bil
Enterprise Value: 366.13 Bil
PE Ratio: 60.57
PB Ratio: 51.09
GF Score: 86/100 Abbvie Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2020 / 07:40PM GMT
Release Date Price:
$86.5
(-17.59%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI biotech team and pleased to welcome from AbbVie, we have Mike Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer; Jeff Stewart, President of U.S. Commercial Operations. Wonderful to have you, gentlemen, here. Thanks for joining us.
Questions & Answers
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
Looking at some of the item script trajectories for RINVOQ and SKYRIZI, it's hard to tell we're in a pandemic. Really, incredible launches. Maybe you can talk and kick things off talking a little bit about the pushes and pulls of these launches in a pandemic and where the headwinds are and tailwinds.
Michael E. Severino
AbbVie Inc. - Vice Chairman & President
Sure. I'll start, and then Rob and Jeff may want to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot